[F&N] YoY Annualized Quarter Result on 31-Mar-2007 [#2]

Stock
[F&N] FRASER & NEAVE HOLDINGS BHD
Announcement Date
03-May-2007
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2007
Quarter
31-Mar-2007 [#2]
Profit Trend
QoQ- -3.24%
YoY- 1.93%
Quarter Report
Latest QR
Upcoming QR
F&N's Result
F&N's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Revenue 3,509,406 3,757,850 3,615,280 2,500,718 2,004,696 1,945,364 1,759,326 12.19%
PBT 393,302 300,974 264,322 213,784 212,520 184,144 168,226 15.19%
Tax -64,900 -73,110 -63,214 -51,270 -54,810 -51,930 -48,732 4.88%
NP 328,402 227,864 201,108 162,514 157,710 132,214 119,494 18.34%
-
NP to SH 325,938 208,464 184,896 148,564 145,744 132,214 119,494 18.19%
-
Tax Rate 16.50% 24.29% 23.92% 23.98% 25.79% 28.20% 28.97% -
Total Cost 3,181,004 3,529,986 3,414,172 2,338,204 1,846,986 1,813,150 1,639,832 11.67%
-
Net Worth 1,337,272 1,213,075 1,152,922 1,121,372 1,085,935 1,057,712 1,020,677 4.60%
Dividend
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Div 117,680 90,713 125,500 85,710 82,302 71,467 56,901 12.86%
Div Payout % 36.11% 43.52% 67.88% 57.69% 56.47% 54.05% 47.62% -
Equity
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Net Worth 1,337,272 1,213,075 1,152,922 1,121,372 1,085,935 1,057,712 1,020,677 4.60%
NOSH 356,606 355,740 356,942 357,125 357,215 357,335 355,636 0.04%
Ratio Analysis
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
NP Margin 9.36% 6.06% 5.56% 6.50% 7.87% 6.80% 6.79% -
ROE 24.37% 17.18% 16.04% 13.25% 13.42% 12.50% 11.71% -
Per Share
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
RPS 984.11 1,056.35 1,012.85 700.24 561.20 544.41 494.70 12.14%
EPS 91.40 58.60 51.80 41.60 40.80 37.00 33.60 18.14%
DPS 33.00 25.50 35.16 24.00 23.04 20.00 16.00 12.81%
NAPS 3.75 3.41 3.23 3.14 3.04 2.96 2.87 4.55%
Adjusted Per Share Value based on latest NOSH - 355,405
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
RPS 956.82 1,024.56 985.68 681.81 546.57 530.39 479.67 12.19%
EPS 88.87 56.84 50.41 40.51 39.74 36.05 32.58 18.19%
DPS 32.08 24.73 34.22 23.37 22.44 19.49 15.51 12.87%
NAPS 3.646 3.3074 3.1434 3.0574 2.9607 2.8838 2.7828 4.60%
Price Multiplier on Financial Quarter End Date
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Date 31/03/10 31/03/09 31/03/08 30/03/07 31/03/06 31/03/05 31/03/04 -
Price 10.58 8.25 7.85 7.35 6.00 5.15 4.20 -
P/RPS 1.08 0.78 0.78 1.05 1.07 0.95 0.85 4.07%
P/EPS 11.58 14.08 15.15 17.67 14.71 13.92 12.50 -1.26%
EY 8.64 7.10 6.60 5.66 6.80 7.18 8.00 1.29%
DY 3.12 3.09 4.48 3.27 3.84 3.88 3.81 -3.27%
P/NAPS 2.82 2.42 2.43 2.34 1.97 1.74 1.46 11.59%
Price Multiplier on Announcement Date
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Date 06/05/10 04/05/09 07/05/08 03/05/07 13/06/06 05/05/05 11/05/04 -
Price 10.72 8.75 8.45 7.35 5.85 5.30 4.06 -
P/RPS 1.09 0.83 0.83 1.05 1.04 0.97 0.82 4.85%
P/EPS 11.73 14.93 16.31 17.67 14.34 14.32 12.08 -0.48%
EY 8.53 6.70 6.13 5.66 6.97 6.98 8.28 0.49%
DY 3.08 2.91 4.16 3.27 3.94 3.77 3.94 -4.01%
P/NAPS 2.86 2.57 2.62 2.34 1.92 1.79 1.41 12.50%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment